Billionaire investor Antonio Gracias has launched a bid to take control of MDMA drug developer Lykos Therapeutics via $100M of funding and a closer alliance to its nonprofit progenitor, MAPS. Gracias heads up Valor Equity Partners, an investment firm with more than $15 billion in assets under management. It accumulated that pile of cash in large part through early bets on companies…